Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Neoplasms

Explore clinical trials studying Pancreatic Neoplasms. Study availability and eligibility vary by location and protocol.

2,458 public trials 581 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Neoplasms trial results

Recruiting

A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening

NCT07612046

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent only) Commack, New York, United States
View Trial Details
Recruiting

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

NCT07621718

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +13 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Piedmont Healthcare Atlanta, Georgia, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
View Trial Details
Recruiting

The Vanguard Study: Testing a New Way to Screen for Cancer

NCT06995898

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Carcinoma, +64 more
Locations
  • Kaiser Permanente-Division of Research Pleasanton, California, United States
  • Keefe Memorial Hospital Cheyenne Wells, Colorado, United States
  • Kaiser Permanente-Franklin Denver, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 39 locations
View Trial Details
Recruiting

Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies

NCT05417594

Conditions
Adnexal Diseases, Advanced Solid Malignancies, Astrocytoma, +36 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site Los Angeles, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Chicago, Illinois, United States
View all 32 locations
View Trial Details
Recruiting

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

NCT06760819

Conditions
Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
Locations
  • UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
  • Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
View all 54 locations
View Trial Details
Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)

NCT07252232

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +10 more
Locations
  • Cedars-Sinai Cancer at Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Los Angeles Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 43 locations
View Trial Details

Related conditions